SCHEMBL8767745

SCHEMBL8767745

Cc1cc(C)nc(-c2cccs2)n1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 5/20 0.50
MAPT P10636 3/20 0.50
MEN1 O00255 2/20 0.50
KMT2A Q03164 2/20 0.50
POLB P06746 2/20 0.50
CYP1A2 P05177 1/20 0.50
CYP3A4 P08684 1/20 0.50
GAA P10253 1/20 0.50
CYP2D6 P10635 1/20 0.50
CYP2C9 P11712 1/20 0.50
CYP2C19 P33261 1/20 0.50
ADORA3 P0DMS8 3/20 0.49
ADORA2A P29274 3/20 0.49
ALDH1A1 P00352 4/20 0.47
KDM4E B2RXH2 4/20 0.47
L3MBTL1 Q9Y468 3/20 0.47
TDP1 Q9NUW8 2/20 0.47
HPGD P15428 1/20 0.47
ADORA1 P30542 2/20 0.45
NPC1 O15118 5/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19148655 0.82 KDM4E (0.58) SMN1; SMN2MAPTMEN1KMT2ACYP1A2
SCHEMBL18483380 0.81 KDM4E (0.48) SMN1; SMN2MAPTMEN1KMT2ACYP1A2
SCHEMBL20110465 0.81 KDM4E (0.48) SMN1; SMN2MAPTMEN1KMT2ACYP1A2
SCHEMBL28960097 0.80 KDM4E (0.56) SMN1; SMN2MAPTMEN1KMT2ACYP1A2
SCHEMBL30104195 0.80 KDM4E (0.56) SMN1; SMN2MAPTMEN1KMT2ACYP1A2
SCHEMBL13377770 0.79 SMN1; SMN2 (0.50) SMN1; SMN2MAPTMEN1KMT2APOLB
SCHEMBL10767350 0.77 MEN1 (0.56) SMN1; SMN2MAPTMEN1KMT2APOLB
SCHEMBL2439328 0.77 NPC1 (0.52) SMN1; SMN2MAPTMEN1KMT2ACYP1A2
SCHEMBL5026243 0.77 KDM4E (0.48) MAPTMEN1KMT2ACYP1A2CYP3A4
SCHEMBL5017827 0.75 RPS6KB2 (0.52) SMN1; SMN2MAPTMEN1KMT2ACYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0513863-B1 Substrates for determination of enzyme activity and intermediates for synthesis of the substrates as well as process for producing the intermediates NITTO BOSEKI CO LTD (JP) 1997-09-03 EP disclosed
EP-0350915-B1 Substrates for determination of enzyme activity NITTO BOSEKI CO LTD (JP) 1994-05-11 EP disclosed
EP-0513863-A1 Substrates for determination of enzyme activity and intermediates for synthesis of the substrates as well as process for producing the intermediates NITTO BOSEKI CO., LTD. (JP) 1992-11-19 EP disclosed
EP-0224255-B1 SYNTHETIC PEPTIDIC SUBSTRATE FOR DETERMINATION OF TRYPSIN AND ALPHA 1-ANTITRYPSIN NITTO BOSEKI CO., LTD. (JP) 1992-06-17 EP disclosed
US-5116941-A PEPTIDE SUBSTRATES FOR DETERMINATION OF ENZYME ACTIVITY NITTO BOSEKI CO., LTD. (JP) 1992-05-26 US disclosed
US-5115099-A Modified tripeptides as substrates for determination of enzyme activity NITTO BOSEKI CO., LTD. (JP) 1992-05-19 US disclosed
EP-0224254-B1 A NOVEL SUBSTRATE FOR PLASMA KALLIKREIN AND A METHOD FOR MEASURING BIOLOGICAL COMPONENTS USING THE SAME NITTO BOSEKI CO., LTD. (JP) 1992-05-06 EP disclosed
US-5063152-A Synthetic peptidic substrate for determination of trypsin and α1 NITTO BOSEKI CO., LTD. (JP) 1991-11-05 US disclosed
EP-0167980-B1 NOVEL SUBSTRATES FOR USE IN MEASURING THE CONCENTRATION OF KALLIKREIN IN URINE NITTO BOSEKI CO., LTD. (JP) 1991-08-07 EP disclosed
EP-0350915-A2 Substrates for determination of enzyme activity NITTO BOSEKI CO., LTD. (JP) 1990-01-17 EP disclosed
US-4894438-A TRIPEPTIDES; ANTIINFLAMMATORY AGENTS NITTO BOSEKI CO., LTD. (JP) 1990-01-16 US disclosed
EP-0347734-A2 Substrates for determination of enzyme activity and intermediates for synthesis of the substrates as well as process for producing the intermediates NITTO BOSEKI CO., LTD. (JP) 1989-12-27 EP disclosed
US-4816562-A Novel substrate for plasma kallikrein and a method for measuring biological components using the same NITTO BOSEKI CO., LTD. (JP) 1989-03-28 US disclosed
EP-0170797-B1 NOVEL SUBSTRATE FOR DETERMINING THE ACTIVITY OF BLOOD COAGULATION FACTOR XA (STUART-PROWER FACTOR) NITTO BOSEKI CO., LTD. (JP) 1987-09-16 EP disclosed
EP-0225175-A2 Dihydropyridine derivatives, processes for their preparation and pharmaceutical compositions thereof FISONS plc (GB) 1987-06-10 EP disclosed
EP-0224255-A2 Synthetic peptidic substrate for determination of trypsin and alpha 1-antitrypsin NITTO BOSEKI CO., LTD. (JP) 1987-06-03 EP disclosed
EP-0224254-A2 A novel substrate for plasma kallikrein and a method for measuring biological components using the same NITTO BOSEKI CO., LTD. (JP) 1987-06-03 EP disclosed
US-4650753-A Novel substrates for use in measuring the concentration of kallikrein in urine NITTO BOSEKI CO., LTD. (JP) 1987-03-17 US disclosed
US-4622389-A Novel substrate for determining the activity of blood coagulation factor Xa (Stuart-Prower factor) Nitto Poseki Co., Ltd. (JP) 1986-11-11 US disclosed
EP-0077124-B1 NOVEL SUBSTRATES FOR MEASURING PLASMIN NITTO BOSEKI CO., LTD. (JP) 1985-03-27 EP disclosed